Genentech and City of Hope Sues Glaxo Group, Human Genome Sciences and Lonza Biologics
April 14, 2011
Genentech and City of Hope files suit against Glaxo Group, Human Genome Sciences, and Lonza Biologics over a patent related to methods of making antibody heavy and light chains having specificity for a desired antigen. 4/12, Central District of California, 2:2011cv03065.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.